Mehta et al. confirmed the involvement of the MEK5/ERK5 pathway in the regulation of prostate cancer cell proliferation [139], potentially linked to the initiation of MEK5/ERK5 signaling and activation of DNA replication licensing pathways in the prostate [140]. Here, MAP2K5 is linked to prostate cancer.